Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 235 (8%)
Anticipated shortage: 19 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-12 2018-09-12 25649
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2018-08-15 29036
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-15 2018-01-31 29348
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-09-04 44507
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-08-15 44510
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-12-12 2019-03-29 69318
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-04 2019-10-01 92984
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-12-05 2020-01-07 100310
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-03-27 2020-05-11 109689
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-01 2020-05-11 110342
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111928
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111931
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114309
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114312
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-09-30 2020-11-19 125369
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-10-21 2020-11-19 126783
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-11-26 148503
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-12-06 148506
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-05-20 2022-07-22 161032
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-06-17 2022-07-28 162904

Showing 2981 to 3000 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71044
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMOXI CLAV 250MG/62.5MG PER 5ML Discontinued 2019-05-13 2019-05-13 83981
APO-AMOXI CLAV Discontinued 2019-05-17 2019-05-18 84392
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CIPROFLOX Discontinued 2019-06-12 2019-06-12 86547
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557

Showing 21 to 40 of 356